2018
DOI: 10.5114/ceh.2018.75954
|View full text |Cite
|
Sign up to set email alerts
|

Surveillance for portal hypertension in the course of liver cirrhosis

Abstract: Non-invasive liver fibrosis assessment techniques are under development for evaluating the severity of liver disease and portal hypertension. The paper presents practical arrangements for the diagnosis and treatment of portal hypertension in patients with chronic liver disease, established in the Baveno VI Consensus Workshop for diagnosis and treatment of portal hypertension. Currently, the diagnostic standard of liver disease severity is transient elastography, which can identify patients with clinically sign… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 21 publications
(26 reference statements)
0
1
0
Order By: Relevance
“…Portal hypertension is a clinical syndrome affecting patients with or without cirrhosis, in which hemodynamic changes in the portosystemic circulation lead to complications such as variceal bleeding, ascites, and portosystemic encephalopathy. [1][2][3] Upper gastrointestinal bleeding caused by esophageal varices is its most serious complication, with an annual bleeding rate of 5-15% and a rebleeding rate of 60% within 1 year. 4 The surgical treatment of portal hypertension primarily aims to prevent esophageal variceal bleeding.…”
Section: Introductionmentioning
confidence: 99%
“…Portal hypertension is a clinical syndrome affecting patients with or without cirrhosis, in which hemodynamic changes in the portosystemic circulation lead to complications such as variceal bleeding, ascites, and portosystemic encephalopathy. [1][2][3] Upper gastrointestinal bleeding caused by esophageal varices is its most serious complication, with an annual bleeding rate of 5-15% and a rebleeding rate of 60% within 1 year. 4 The surgical treatment of portal hypertension primarily aims to prevent esophageal variceal bleeding.…”
Section: Introductionmentioning
confidence: 99%